(Q40574671)

21 September 2017

1 reference

title

Effects of nerve growth factor in primate models of neurodegeneration: potential relevance in clinical neurology (English)

1 reference

21 September 2017

Liberini P

1

1 reference

PubMed ID

7827710

21 September 2017

Cuello AC

series ordinal

2

1 reference

21 September 2017

1 April 1994

1 reference

Reviews in the Neurosciences

21 September 2017

1 reference

21 September 2017

5

1 reference

21 September 2017

89-104

1 reference

21 September 2017

2

1 reference

Distribution of beta-nerve growth factor receptors in the human basal forebrain

21 September 2017

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Keeping track of neurotrophin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Nerve growth factor action is mediated by cyclic AMP- and Ca+2/phospholipid-dependent protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Retrograde changes in the nucleus basalis of the rat, caused by cortical damage, are prevented by exogenous ganglioside GM1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Magnocellular nuclei of the basal forebrain project to neocortex, brain stem, and olfactory bulb. Review of some functional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Transient expression of NGF-receptor-like immunoreactivity in postnatal rat brain and spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Morphological response of axotomized septal neurons to nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Senile plaques as aberrant sprout-stimulating structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Target cells, biological effects, and mechanism of action of nerve growth factor and its antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Immunocytochemical identification of cholinergic neurons in the monkey central nervous system using monoclonal antibodies against choline acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Neuronal loss or replacement in the injured adult cerebral neocortex induces extensive remodeling of intrinsic and afferent neural systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Expression and structure of the human NGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Fiber pathways of basal forebrain cholinergic neurons in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

The trk proto-oncogene encodes a receptor for nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Nerve growth factor treatment after brain injury prevents neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Induction of the proto-oncogene fos by nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Alz-50 immunoreactivity in the central nervous system of adult rat and primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Neurotrophin-3: a neurotrophic factor related to NGF and BDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Effects of microencapsulated monosialoganglioside GM1 on cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Microencapsulation of genetically engineered fibroblasts secreting nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Observations on the fornix of the monkey. I. Cell studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Three-dimensional representation and cortical projection topography of the nucleus basalis (Ch4) in the macaque: concurrent demonstration of choline acetyltransferase and retrograde transport with a stabilized tetramethylbenzidine method for horsera

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Nerve growth factor rapidly induces c-fos mRNA in PC12 rat pheochromocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Nerve growth factor receptor immunoreactivity in the new world monkey (Cebus apella) and human cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

p75 nerve growth factor receptor immunoreactivity in the human brainstem and spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Basic fibroblast growth factor and nerve growth factor administered in gel foam rescue medial septal neurons after fimbria fornix transection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Retrograde cell degeneration in the basal nucleus in monkey and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Potential use of nerve growth factor to treat Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Primate nucleus basalis of Meynert p75NGFR-containing cholinergic neurons are protected from retrograde degeneration by the ganglioside GM1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Ganglioside function in the development and repair of the nervous system. From basic science to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Parenterally administered GM1 ganglioside prevents retrograde degeneration of cholinergic cells of the rat basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Survival of Adult Basal Forebrain Cholinergic Neurons After Loss of Target Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Neural plasticity of basal forebrain cholinergic neurons: effects of gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Brain biocompatibility of a biodegradable, controlled-release polymer in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Interactions of GM1 ganglioside with crude rat brain neuronal membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

An improved device for continuous intraventricular infusions prevents the introduction of pump-derived toxins and increases the effectiveness of NGF treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Evidence for a physiological role of nerve growth factor in the central nervous system of neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

Molecular cloning and expression of brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1994.5.2.89

10.1515/REVNEURO.1994.5.2.89

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7827710